Fenbendazole 1000 mg is a broad-spectrum antiparasitic oral tablet from the benzimidazole family. Traditionally used in veterinary medicine to treat parasitic infections in animals such as dogs, cattle, and horses, it works by disrupting microtubule formation in parasites, preventing them from surviving and reproducing.

This product is formulated in high-purity, pharmaceutical-grade quality suitable for human-use research and physician-supervised protocols.

Uses of Fenbendazole 1000 mg

Veterinary Use

• Treatment of roundworms, hookworms, whipworms, and tapeworms in animals

• Safe for dogs, cattle, horses, and other livestock under veterinary guidance

Emerging Human Research

• Off-label use in integrative cancer support

• Used as part of protocols like the Shakman Protocol, combining antiparasitic agents, antibiotics, and immune modulators to target cancer

• Research and case reports suggest potential anticancer properties, though it is not FDA-approved for cancer treatment

Mechanism of Action

Fenbendazole 1000 mg interferes with the formation of microtubules, essential structures for parasites’ cellular function. This disruption prevents parasite survival and reproduction.

In experimental and off-label cancer protocols, Fenbendazole may impact cancer cells by interfering with metabolic and structural pathways, though human clinical evidence is limited and physician supervision is recommended.

Dosage & Administration

• For research or physician-supervised protocols only

• Typically administered orally, with dosage based on protocol specifications or professional guidance

• Take with water, preferably after a meal to improve tolerability

Common Side Effects

• Mild nausea or gastrointestinal discomfort

• Rare headaches or fatigue

• Temporary digestive changes

Serious Side Effects

• Allergic reactions (rash, swelling, breathing difficulty)

• Persistent gastrointestinal issues

• Liver function abnormalities in prolonged use

Drug Interactions

• Consult a physician for interactions with prescription medications

• Caution with liver-metabolized drugs

Food & Lifestyle Interactions

• Take with food to reduce stomach irritation

• Maintain hydration during administration

• Follow protocol-specific guidance for diet and supplementation

Monitoring & Tests

• Liver function tests for prolonged or repeated use

• Physician supervision recommended for research-based or off-label protocols

Precautions & Warnings

• Not FDA-approved for cancer treatment in humans

• Use only under physician supervision or research protocols

• Avoid in individuals with known allergy to benzimidazoles

• Not recommended during pregnancy or breastfeeding